Sugi Predict
/ Targets
/ GHITM
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to GHITM by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy Subjects |
PHASE4 | UNKNOWN |
| A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood |
PHASE4 | COMPLETED |
| Growth Hormone and Glucose Metabolism |
PHASE4 | COMPLETED |
| Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction |
PHASE4 | COMPLETED |
| Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency |
PHASE3 | COMPLETED |
| Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus |
PHASE3 | COMPLETED |
| The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature |
PHASE3 | RECRUITING |
| A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation |
PHASE3 | UNKNOWN |
| Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary |
PHASE3 | COMPLETED |
| Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia |
PHASE2 | COMPLETED |
| Growth Hormone Treatment in Children With Phelan McDermid Syndrome |
PHASE2 | COMPLETED |
| Growth Hormone in a Patient With a Dominant-Negative GHR Mutation |
PHASE2 | ACTIVE_NOT_RECRUITING |
| Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children |
PHASE2 | COMPLETED |
| Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) |
PHASE2 | RECRUITING |
| Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency |
PHASE2 | COMPLETED |
| Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers |
PHASE1 | WITHDRAWN |
| A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) |
PHASE1 | RECRUITING |
| A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency |
PHASE1 | COMPLETED |
| Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT) |
nan | COMPLETED |
| Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine |
nan | COMPLETED |
| Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA. |
nan | COMPLETED |
| Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA |
nan | RECRUITING |
| Consequence of Lifetime Isolated Growth Hormone Deficiency |
nan | COMPLETED |
| A Study to Assess Growth in Children With Idiopathic Short Stature |
nan | RECRUITING |
| D3-GHR Polymorphism and Turner Syndrome |
nan | COMPLETED |
| Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection. |
nan | COMPLETED |
| miRNA as a Growth Plate Marker After GH |
nan | UNKNOWN |
| The Relationship Between Body Composition and Growth Hormone, SIRT Signaling, Protein Turnover and Insulin Sensitivity |
nan | COMPLETED |
| Adipose Tissue and Serum Inflammation in GH Deficiency |
nan | COMPLETED |
| Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a GHITM binder may also engage these)